Halozyme Therapeutics Director Buys 50K Shares and 4 Insider Buys to Note

Falberg Kathryn E who is Director at Halozyme Therapeutics, Inc. (NASDAQ:HALO), bought 50,000 shares at $6.91 per share for a total value of $345,710. The shares recently traded at $6.92, up $0.01, or 0.14% since the insider buy.

halo-20130816

Fisherman Jason S who is Director at Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), bought 5,000 shares at $6.83 per share for a total value of $34,150. The shares recently traded at $6.71, down $0.12, or 1.76% since the insider buy.

ACHN-20130816

Global Gp Llc who is General Partner at Global Partners LP (NYSE:GLP), bought 17,400 shares at $34.42 per share for a total value of $598,908. The shares recently traded at $33.86, down $0.56, or 1.63% since the insider buy.

GLP-20130816

Peacock Douglas W who is Director at TransDigm Group Incorporated (NYSE:TDG), bought 3,000 shares at $139.59 per share for a total value of $418,772. The shares recently traded at $137.9, down $1.69, or 1.21% since the insider buy.

TDG-20130816

Sims Frank L who is Director at South Jersey Industries, Inc. (NYSE:SJI), bought 4,500 shares at $59.99 per share for a total value of $269,964. The shares recently traded at $58.22, down $1.77, or 2.95% since the insider buy.

SJI-20130816

Don’t Miss: Movie This Weekend? Here Are 4 Top Picks.

More Articles About:    

More from The Cheat Sheet